127 results
6-K
EX-99.1
APTO
Aptose Biosciences Inc
29 Sep 14
Aptose Biosciences Joins The Leukemia & Lymphoma Society's Groundbreaking Beat AML Research Initiative with Oregon Health & Science University
12:00am
(OHSU) and The Leukemia & Lymphoma Society (LLS) today announced that Aptose has joined the Beat AML collaboration. Beat AML is a groundbreaking research … with The Leukemia & Lymphoma Society. Its goal is to accelerate development of potential therapies for acute myeloid leukemia (AML).
Aptose's lead investigational
6-K
EX-99.9
APTO
Aptose Biosciences Inc
6 Feb 14
Lorus Therapeutics to Present at Biotech ShowcaseTM 2014
12:00am
for Clinical Research (often referred to as America’s Nobel), the Japan Prize and top awards from the American Cancer Society, the Lance Armstrong Foundation … , American Society of Hematology, and the Leukemia and Lymphoma Society, among others. He was elected to the Institute of Medicine of the National
6-K
EX-99.1
APTO
Aptose Biosciences Inc
20 Nov 18
Aptose to Participate in Upcoming Investor Conferences, Host Key Opinion Leader Event, and Present Data at the Upcoming ASH Meeting
7:05am
Society of Hematology (ASH) Annual Meeting and Exposition:
Piper Jaffray 19th Annual Health Care Conference
Time: 4:00 pm ET
Date: Tuesday, November 27 … event is by invitation only (contact Morgen Alden, Morgen@lifesciadvisors.com) and will also be accessible by webcast.
American Society of Hematology
8-K
EX-99.1
APTO
Aptose Biosciences Inc
13 Dec 21
HM43239 Data Featured in Oral Presentation at the American Society of Hematology Annual Meeting
4:35pm
Society of Hematology Annual Meeting
Aptose Presents Highlights from Luxeptinib and APTO-253 and Provides Corporate Update
SAN DIEGO, TORONTO … in an oral presentation today at the 2021 American Society of Hematology (ASH) Annual meeting by lead investigator Naval G. Daver, M.D., Associate
6-K
EX-99.43
APTO
Aptose Biosciences Inc
19 Nov 03
Current report (foreign)
12:00am
THERAPEUTICS PARTICIPATES AT THE THIRTY-NINTH ANNUAL MEETING OF
THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY
TSX: LOR
OTC BB: LORFF … ) will
be presented at the annual meeting of the American Society of Clinical Oncology
(ASCO), May 31" to June 3 degrees degrees 2003, in Chicago, Illinois
6-K
EX-99
qgbad
14 Oct 04
Current report (foreign)
12:00am
6-K
wx98csp2kgxt
18 May 05
Current report (foreign)
12:00am
6-K
EX-99.1
ycqi26q0
25 Oct 06
Lorus Therapeutics Announces Presentation of
12:00am
6-K
EX-99.1
gh4rp7ghv9
3 Dec 14
Aptose Biosciences to Present Preclinical Research Update for APTO-253 at the 56th American Society of Hematology Annual Meeting
12:00am
6-K/A
EX-99
d48br
23 Mar 05
Current report (foreign) (amended)
12:00am
6-K
EX-99
nyiy9o 05
22 Mar 05
Current report (foreign)
12:00am
6-K
EX-99.1
v6ic910u
9 Dec 14
Aptose Biosciences Presents APTO-253 Preclinical Data at 56th American Society of Hematology Annual Meeting
12:00am
6-K
d48jm95peg96j28
9 Dec 14
Aptose Biosciences Presents APTO-253 Preclinical Data at 56th American Society of Hematology Annual Meeting
12:00am
6-K
bgy4j 1j4ax
3 Dec 14
Aptose Biosciences to Present Preclinical Research Update for APTO-253 at the 56th American Society of Hematology Annual Meeting
12:00am
8-K
EX-99.1
n692cszg ww72
9 Nov 23
Aptose Reports Results for the Third Quarter 2023
4:15pm
8-K
EX-99.1
zyc92fm3gip qi4y
2 Nov 23
Aptose Tuspetinib Clinical Data Selected for Oral Presentation at the 2023 ASH Annual Meeting
9:15am
8-K
EX-99.1
ynqfvk3v
3 Nov 22
Aptose Clinical Data to be Presented at the 2022 ASH Annual Meeting
9:10am
6-K
EX-99.1
igol7v4fna
3 Mar 15
Current report (foreign)
12:00am
8-K
EX-99.1
hg2mk z608o7nzhhkg60
7 Dec 22
Aptose to Hold Clinical Update and Data Review of AML Drug Tuspetinib on Sunday, December 11th
4:15pm
6-K
EX-99.1
wsyyjhs
19 Nov 03
Current report (foreign)
12:00am